391 results on '"Lang I."'
Search Results
2. Process evaluation of a New psychosocial goal-setting and manualised support intervention for Independence in Dementia (NIDUS-Family)
3. Effect of alirocumab on quantitative flow ratio and diameter stenosis in non-infarct related arteries from patients with acute myocardial infarction: a PACMAN-AMI randomized clinical trial substudy
4. PCSK9-inhibitor therapy leads to changes in immune cell gene expression and function: A subset analysis of the PACMAN-AMI trial
5. Clinical outcomes in patients receiving oral anticoagulation stratified by the presence of dose reduction criteria and older age: a subanalysis of ENVISAGE-TAVI AF
6. Routinely available inflammation biomarkers as predictors of adverse outcomes following coronary angiography
7. PAH-specific treatment for patients with combined pre- and post-capillary pulmonary hypertension
8. Association of inflammatory activation with acute stent thrombosis
9. Frequency, predictors and clinical outcomes of AMI patients with triple regression of coronary atherosclerosis: A sub-analysis of the PACMAN AMI trial
10. Increased in-hospital complication risk in women undergoing chronic total occlusion recanalization
11. Effectiveness and safety of catheter-directed thrombolysis for acute pulmonary embolism: a systematic review and meta-analysis
12. PB0462 Early Discharge and Home Treatment of Patients with Acute Pulmonary Embolism in the Tertiary Care Setting
13. (851) ARTISAN: A Novel Study of Mean Pulmonary Artery Pressure-Targeted Approach with Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling in Pulmonary Arterial Hypertension
14. Characteristics, management, disposition, and outcome of patients with pulmonary embolism in a tertiary care setting
15. INCREASED SUPAR SERUM CONCENTRATIONS IN PATIENTS WITH LEFT AND RIGHT VENTRICULAR REMODELING DUE TO PRESSURE OVERLOAD IS ASSOCIATED WITH MYOCARDIAL MASS
16. Gene expression profile at week 2 of neoadjuvant therapy course predicts outcome in HER2-positive breast cancer patients: an explorative analysis from NeoALTTO
17. Plasma eicosanoid profiling in the course of proprotein convertase subtilisin-kexin type 9 inhibition: insights from a metabolomic analysis
18. Interrelation between baseline plaque characteristics and changes in coronary atherosclerosis with the PCSK9-inhibitor alirocumab: insights from the PACMAN-AMI randomized trial
19. Chronic thromboembolic pulmonary hypertension and left ventricular filling pressures
20. Natural IgM attenuate formation of neutrophil extracellular traps induced by oxidation-specific epitopes in vitro and in vivo
21. The prognostic value of vasoresponse to nitric oxide in patients with chronic thromboembolic pulmonary hypertension
22. Serum uric acid and long-term survival in patients with pulmonary arterial hypertension(group 1 and 4) – results from a single pulmonary hypertension centre in Slovenia
23. Improvement of risk in patients with severe chronic thromboembolic pulmonary hypertension after 24weeks treatment with subcutaneous treprostinil
24. Medical bridging therapy before pulmonary endarterectomy?
25. Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension improves sleep-disordered breathing
26. Behandler:innenperspektive auf die Versorgungsstrukturen für Patient:innen mit äthyltoxischer Zirrhose in Vorbereitung auf eine Lebertransplantation. Herausforderungen an der Schnittstelle zwischen Transplantationszentrum und Suchthilfesystem sowie Barrieren im Suchthilfesystem
27. The APPLE Tree programme: Active Prevention in People at risk of dementia through Lifestyle, bEhaviour change and Technology to build REsiliEnce—randomised controlled trial
28. ERS statement on chronic thromboembolic pulmonary hypertension
29. 2020 ESC Guidelines for themanagement of adult congenital heart disease
30. Response to anticoagulation in chronic thromboembolic pulmonary hypertension
31. Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication
32. Cerebral protection in TAVR – can we do without? Impact on stroke rate, length of hospital stay and 12-month mortality
33. Efficacy and safety of percutaneous pulmonary artery subtotal occlusion and CTO intervention in chronic thromboembolic pulmonary hypertension
34. Treatment effect of selexipag on time to disease progression when initiated early in pulmonary arterial hypertension (PAH) patients: GRIPHON and TRITON pooled analysis
35. eCPRI Radio Access Network Fronthaul Physical Reach Increase by using Hollow Core Fibre
36. Anticoagulation for stroke prevention in patients with atrial fibrillation on hemodialysis is associated with net-clinical harm
37. A realist evaluation of a collaborative model to support research co-production in long-term care settings in England: the ExCHANGE protocol
38. The role of asymmetric dimethylarginine (ADMA) in the follow-up of patients with precapillary pulmonary hypertension (PH)
39. Adaptive development of concomitant secondary mitral and tricuspid regurgitation after TAVR
40. Detection of Factor VIII-Specific Memory B Cells in Patients with Hemophilia A and Factor VIII Inhibitors
41. Frailty: A cost incurred by reproduction?
42. Intestinal Commensal Bacteria Promote AT2 Self-Renewal and AT1 Differentiation in an IL-22 Dependent Fashion and Prepare the Newborn to Fight Potentially Fatal Respiratory Pathogens
43. Vesikovaginale Fisteln: Diagnostik und operatives Management
44. Everolimus plus exemestane in hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer: incidence and time course of adverse events in the phase IIIb BALLET population
45. Efficacy and safety of selexipag in pulmonary arterial hypertension (PAH) patients with and without significant cardiovascular (CV) comorbidities
46. The impact of time from diagnosis at baseline on long-term outcome in the GRIPHON Study: Selexipag in pulmonary arterial hypertension (PAH)
47. P1739 Diameter of the pulmonary artery in relation to the ascending aorta: a promising parameter for the diagnosis of pulmonary hypertension
48. Optical Transmission of Macroporous Silicon
49. Focus on Pathophysiology, Diagnosis and Management of Chronic Thromboembolic Disease
50. P6010Deficiency in milk fat globule-epidermal growth factor 8 delays thrombus resolution
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.